115 related articles for article (PubMed ID: 37750446)
21. Tumor Volume Reduction After Gemcitabine Plus Cisplatin Induction Chemotherapy in Locally Advanced Nasopharyngeal Cancer: Comparison with Paclitaxel and Cisplatin Regimens.
Zheng L; Liao W; Xu P; Li B; Wen H; Zhang S
Med Sci Monit; 2018 Nov; 24():8001-8008. PubMed ID: 30406770
[TBL] [Abstract][Full Text] [Related]
22. Sequential induction chemotherapy plus intensity-modulated radiotherapy versus concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: the three-year report of a phase II, single center, randomized, non-inferiority trial.
Yang Z; Cai Z; Cai Q; Hong Y; Zhang C; Huang K; Lin Z; Li M
Cancer Med; 2021 Jun; 10(12):3886-3895. PubMed ID: 33955190
[TBL] [Abstract][Full Text] [Related]
23. [Dynamic observation on the short-term change of xerostomia after intensity-modulated radiotherapy for patients with nasopharyngeal carcinoma].
Li Y; Zhao C
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 Jan; 50(1):33-7. PubMed ID: 25764925
[TBL] [Abstract][Full Text] [Related]
24. Impact of tumor volume enlargement after induction chemotherapy on subsequent radiotherapy in locally advanced nasopharyngeal carcinoma: A propensity-score matching analysis.
Li S; Shen L
Cancer Med; 2020 Dec; 9(23):8832-8843. PubMed ID: 33022902
[TBL] [Abstract][Full Text] [Related]
25. [Impact of changing gross tumor volume delineation of intensity-modulated radiotherapy on the dose distribution and clinical treatment outcome after induction chemotherapy for the primary locoregionally advanced nasopharyngeal carcinoma].
Yu Z; Luo W; Zhou QC; Zhang QH; Kang DH; Liu MZ
Ai Zheng; 2009 Nov; 28(11):1132-7. PubMed ID: 19895731
[TBL] [Abstract][Full Text] [Related]
26. Treatment outcomes after reduction of the target volume of intensity-modulated radiotherapy following induction chemotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: A prospective, multi-center, randomized clinical trial.
Yang H; Chen X; Lin S; Rong J; Yang M; Wen Q; Shang C; He L; Ren P; Xu S; Zhang J; Liu Q; Pang H; Shi X; Fan J; Sun X; Ma D; Tan B; Zhang T; Zhang L; Hu D; Du X; Zhang Y; Wen S; Zhang X; Wu J
Radiother Oncol; 2018 Jan; 126(1):37-42. PubMed ID: 28864073
[TBL] [Abstract][Full Text] [Related]
27. Risk stratification and beneficiary selection among elderly nasopharyngeal carcinoma patients from concurrent chemoradiotherapy combined with induction chemotherapy.
He S; Wu YL; Gao Y; He D; Huang Y
Cancer Med; 2023 May; 12(9):10536-10552. PubMed ID: 37062057
[TBL] [Abstract][Full Text] [Related]
28. Optimizing induction chemotherapy regimens for radiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma.
Li Y; Bi J; Pi G; He H; Li Y; Zheng D; Wei Z; Han G
Cancer Med; 2023 Apr; 12(8):9449-9457. PubMed ID: 36872566
[TBL] [Abstract][Full Text] [Related]
29. Comparison of induction chemotherapy plus concurrent chemoradiotherapy and induction chemotherapy plus radiotherapy in locally advanced nasopharyngeal carcinoma.
Wang Q; Xu G; Xia Y; Zuo J; Zeng G; Xue Z; Cao R; Xiong W; Li W
Oral Oncol; 2020 Dec; 111():104925. PubMed ID: 32721816
[TBL] [Abstract][Full Text] [Related]
30. [Primary effect of submandibular salivary gland transfer in preventing radiation-induced xerostomia of nasopharyngeal carcinoma].
Liu XK; Zeng ZY; Hong MH; Cui NJ; Su Y; Mai HQ; Chen FJ
Ai Zheng; 2005 May; 24(5):577-81. PubMed ID: 15890101
[TBL] [Abstract][Full Text] [Related]
31. [Clinical efficacy of alternating chemo-radiotherapy for locally advanced nasopharyngeal carcinoma].
You X; Yang Y
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Mar; 28(6):376-80. PubMed ID: 24961123
[TBL] [Abstract][Full Text] [Related]
32. Salivary gland function in nasopharyngeal carcinoma before and late after intensity-modulated radiotherapy evaluated by dynamic diffusion-weighted MR imaging with gustatory stimulation.
Shi D; Qian JJ; Fan GH; Shen JK; Tian Y; Xu L
BMC Oral Health; 2019 Dec; 19(1):288. PubMed ID: 31864328
[TBL] [Abstract][Full Text] [Related]
33. Definitive intensity-modulated radiation therapy for nasopharyngeal carcinoma: long-term outcome of a multicenter prospective study.
Wang R; Wu F; Lu H; Wei B; Feng G; Li G; Liu M; Yan H; Zhu J; Zhang Y; Hu K
J Cancer Res Clin Oncol; 2013 Jan; 139(1):139-45. PubMed ID: 22986812
[TBL] [Abstract][Full Text] [Related]
34. Induction chemotherapy plus IMRT alone versus induction chemotherapy plus IMRT-based concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: a retrospective cohort study.
Wei Z; Zhang Z; Luo J; Li N; Peng X
J Cancer Res Clin Oncol; 2019 Jul; 145(7):1857-1864. PubMed ID: 31062162
[TBL] [Abstract][Full Text] [Related]
35. Submandibular salivary gland transfer for the prevention of radiation-induced xerostomia in patients with nasopharyngeal carcinoma: 5-Year outcomes.
Liu XK; Su Y; Jha N; Hong MH; Mai HQ; Fan W; Zeng ZY; Guo ZM
Head Neck; 2011 Mar; 33(3):389-95. PubMed ID: 20629074
[TBL] [Abstract][Full Text] [Related]
36. Comparison of the pre-treatment functional MRI metrics' efficacy in predicting Locoregionally advanced nasopharyngeal carcinoma response to induction chemotherapy.
Zhao DW; Fan WJ; Meng LL; Luo YR; Wei J; Liu K; Liu G; Li JF; Zang X; Li M; Zhang XX; Ma L
Cancer Imaging; 2021 Nov; 21(1):59. PubMed ID: 34758876
[TBL] [Abstract][Full Text] [Related]
37. Induction Chemotherapy Followed by Radiotherapy versus Concurrent Chemoradiotherapy in elderly patients with nasopharyngeal carcinoma: finding from a propensity-matched analysis.
Zeng Q; Wang J; Lv X; Li J; Yin LJ; Xiang YQ; Guo X
BMC Cancer; 2016 Aug; 16(1):693. PubMed ID: 27577729
[TBL] [Abstract][Full Text] [Related]
38. Effect of induction chemotherapy with cisplatin, fluorouracil, with or without taxane on locoregionally advanced nasopharyngeal carcinoma: a retrospective, propensity score-matched analysis.
Liu GY; Lv X; Wu YS; Mao MJ; Ye YF; Yu YH; Liang H; Yang J; Ke LR; Qiu WZ; Huang XJ; Li WZ; Guo X; Xiang YQ; Xia WX
Cancer Commun (Lond); 2018 May; 38(1):21. PubMed ID: 29764487
[TBL] [Abstract][Full Text] [Related]
39. Individualized number of induction chemotherapy cycles for locoregionally advanced nasopharyngeal carcinoma patients based on early tumor response.
Jiang YT; Chen KH; Liang ZG; Yang J; Qu S; Li L; Zhu XD
Cancer Med; 2023 Feb; 12(4):4010-4022. PubMed ID: 36127746
[TBL] [Abstract][Full Text] [Related]
40. Submandibular gland sparing in intensity-modulated radiotherapy for N0-stage nasopharyngeal carcinoma.
Huang L; Zhang W; Zhuang T; Wu F; Li D; Zheng M; Lin B; Zhuang M; Chen Z
Br J Radiol; 2014 Apr; 87(1036):20130651. PubMed ID: 24620926
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
